Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Allena Pharmaceuticals Announces $15.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules – NASDAQ News Today – EIN News

Trusted News Since 1995

A service for global professionals · Wednesday, June 3, 2020 · 518,577,421 Articles · 3+ Million Readers News Monitoring and Press Release Distribution Tools News Topics Newsletters Press Releases Events & Conferences RSS Feeds Other Services Questions?

Read More Here...

Bookmark the permalink.

Comments are closed.